Valneva SE (VALN) Asset Utilization Ratio (2022 - 2026)
Valneva SE's (VALN) quarterly Asset Utilization Ratio came in at 0.36 in Q1 2026, down 2.93% year-on-year from 0.37 in Q1 2025, and little changed quarter-over-quarter from 0.36 in Q4 2025.
Valneva SE (VALN) Asset Utilization Ratio (2022 - 2026) Analysis & Trends
Valneva SE has disclosed Asset Utilization Ratio across 5 years of filings, most recently posting 0.36 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.36, down 2.93% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.36 (down 2.93% YoY), and the FY2025 annual result was 0.37, up 8.57% from the prior year.
- Asset Utilization Ratio came in at 0.36 for Q1 2026 at Valneva SE, roughly flat from 0.36 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.39 in Q2 2025 to a low of 0.08 in Q1 2022.
- The 5-year median for Asset Utilization Ratio is 0.31 (2024), against an average of 0.27.
- Across the five-year window, Asset Utilization Ratio jumped 192.45% in 2023 and decreased 2.93% in 2026, its largest moves.
- Valneva SE's Asset Utilization Ratio stood at 0.18 in 2022, then surged by 75.92% to 0.31 in 2023, then grew by 2.41% to 0.32 in 2024, then gained by 11.76% to 0.36 in 2025, then rose by 0.29% to 0.36 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.36 (Q1 2026), 0.36 (Q4 2025), and 0.35 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 0.55 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.36 |
| Dec 31, 2025 | 0.36 |
| Sep 30, 2025 | 0.35 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.37 |
| Dec 31, 2024 | 0.32 |
| Sep 30, 2024 | 0.32 |
| Jun 30, 2024 | 0.31 |
| Mar 31, 2024 | 0.32 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.26 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 0.18 |
| Sep 30, 2022 | 0.13 |
| Jun 30, 2022 | 0.09 |
| Mar 31, 2022 | 0.08 |